Center for Instrumental Analysis, China Pharmaceutical University, Nanjing, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Jiangsu 210009, People's Republic of China.
Expert Opin Investig Drugs. 2011 Oct;20(10):1311-25. doi: 10.1517/13543784.2011.611500. Epub 2011 Aug 26.
This perspective is a paper discussing drugs dropped from clinical development in the previous years. Specifically, this paper focuses on 16 cardiovascular drugs discontinued in 2010 after reaching Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.
这是一篇讨论前些年从临床开发中撤药的观点文章。具体来说,本文重点讨论了 2010 年在完成 I 期-III 期临床试验后停止开发的 16 种心血管药物。本文观点的信息主要来源于 Pharmaprojects 的检索。